These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1546547)

  • 21. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M; Xiao S
    Am J Psychiatry; 2004 Feb; 161(2):343-51. PubMed ID: 14754784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls.
    Eriksson E; Sundblad C; Lisjö P; Modigh K; Andersch B
    Psychoneuroendocrinology; 1992; 17(2-3):195-204. PubMed ID: 1438645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder.
    Landén M; Nissbrandt H; Allgulander C; Sörvik K; Ysander C; Eriksson E
    Neuropsychopharmacology; 2007 Jan; 32(1):153-61. PubMed ID: 17035933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.
    Schmidt PJ; Grover GN; Rubinow DR
    Arch Gen Psychiatry; 1993 Jun; 50(6):467-73. PubMed ID: 8498881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. To what extent do premenstrual and interictal dysphoric disorder overlap? Significance for therapy.
    Blumer D; Herzog AG; Himmelhoch J; Salgueiro CA; Ling FW
    J Affect Disord; 1998 Mar; 48(2-3):215-25. PubMed ID: 9543212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.
    Cohen LS; Miner C; Brown EW; Freeman E; Halbreich U; Sundell K; McCray S
    Obstet Gynecol; 2002 Sep; 100(3):435-44. PubMed ID: 12220761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
    Freeman EW; Sondheimer SJ; Rickels K
    Psychopharmacol Bull; 1997; 33(2):303-9. PubMed ID: 9230648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.
    Thys-Jacobs S; Starkey P; Bernstein D; Tian J
    Am J Obstet Gynecol; 1998 Aug; 179(2):444-52. PubMed ID: 9731851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria.
    Eriksson E
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S27-33. PubMed ID: 10471170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of premenstrual dysphoria with alprazolam. A controlled study.
    Harrison WM; Endicott J; Nee J
    Arch Gen Psychiatry; 1990 Mar; 47(3):270-5. PubMed ID: 2407209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serotonin uptake inhibitors provide rapid relief from premenstrual dysphoria. New findings shed light on how serotonin modulates sex hormone-related behavior].
    Eriksson E; Andersch B; Ho HP; Landén M; Sundblad C
    Lakartidningen; 2001 Aug; 98(34):3524-30. PubMed ID: 11571794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoxetine's spectrum of action in premenstrual syndrome.
    Menkes DB; Taghavi E; Mason PA; Howard RC
    Int Clin Psychopharmacol; 1993; 8(2):95-102. PubMed ID: 8345163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian morphology in premenstrual dysphoria.
    Eriksson O; Landén M; Sundblad C; Holte J; Eriksson E; Naessén T
    Psychoneuroendocrinology; 2012 Jun; 37(6):742-51. PubMed ID: 21974977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mood changes correlate to changes in brain serotonin precursor trapping in women with premenstrual dysphoria.
    Eriksson O; Wall A; Marteinsdottir I; Agren H; Hartvig P; Blomqvist G; Långström B; Naessén T
    Psychiatry Res; 2006 Mar; 146(2):107-16. PubMed ID: 16515859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between premenstrual dysphoria and daily ratings dimensions.
    Christensen AP; Oei TP; Callan VJ
    J Affect Disord; 1989; 16(2-3):127-32. PubMed ID: 2522111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment.
    Sundblad C; Wikander I; Andersch B; Eriksson E
    Eur Neuropsychopharmacol; 1997 Aug; 7(3):201-6. PubMed ID: 9213079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The measurement of premenstrual mood symptoms.
    Steiner M; Streiner DL; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D
    J Affect Disord; 1999 Jun; 53(3):269-73. PubMed ID: 10404713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study.
    Wang M; Hammarbäck S; Lindhe BA; Bäckström T
    Acta Obstet Gynecol Scand; 1995 Nov; 74(10):803-8. PubMed ID: 8533564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial.
    Brown CS; Ling FW; Andersen RN; Farmer RG; Arheart KL
    Obstet Gynecol; 1994 Nov; 84(5):779-86. PubMed ID: 7936512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Incidence and type of premenstrual symptoms in relation to experienced infertility: a comparative study].
    Rohde A; Marneros A; Fischer J; Diedrich K
    Geburtshilfe Frauenheilkd; 1992 May; 52(5):291-6. PubMed ID: 1612406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.